AI-Powered Healthcare Stocks Poised for Growth Amid Slow Industry Adoption
Artificial intelligence continues to transform industries, yet healthcare remains a cautious adopter. While sectors like autonomous vehicles and chatbots race ahead, medical applications progress deliberately—creating undervalued opportunities.
Recursion Pharmaceuticals exemplifies this trend. The biotech firm leverages AI to slash drug development costs, targeting a market where failed trials typically burn hundreds of millions. Its approach could disrupt the traditional pharmaceutical model.